Top Markets
Coin of the day
Wellnex Life Limited Wellnex Life Limited

Wellnex Life Limited

WNX
Classement en actions #34869
Wellnex Life Limited, together with its subsidiaries, develops, markets, and... Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Prix de l'action
$0.06559149
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$4.79M
Changement (1 jour)
1.09%
Changement (1 an)
-61.95%
Pays
AU
Échange Wellnex Life Limited (WNX)
Bénéfices pour Wellnex Life Limited (WNX)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Wellnex Life Limited, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Wellnex Life Limited de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$2.28B -
US
$961.00M -
US
$485.80M -
US
$133.52M -
US
$93.16M -
SG